LPL Financial’s CervoMed CRVO Stock Holding History

LPL Financial’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-974	Closed	-$18K	–	4443
2022 Q1	$18K	Buy	+974	New	+$19.3K	﹤0.01%	4128

Other funds holding CRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

LPL Financial's CRVO Position: Q2 2022 in Review

LPL Financial sold out of CervoMed (CRVO) in Q2 2022, closing a stake of 974 shares — an estimated $18K sold.

LPL Financial first reported a position in CRVO in Q1 2022 and held it in 1 quarter. The position peaked at $18K in Q1 2022. 15 funds tracked by Wall St. Rank hold CRVO as of Q2 2022.

LPL Financial reported no remaining CervoMed position as of Q2 2022 after selling out during the quarter.
LPL Financial sold 974 CervoMed shares in Q2 2022, an estimated $18K.
LPL Financial first reported a position in CervoMed in Q1 2022 and held it in 1 quarter.
LPL Financial's CervoMed position peaked at $18K in Q1 2022.
15 funds tracked by Wall St. Rank held CervoMed as of Q2 2022.

Based on LPL Financial's 13F filing for Q2 2022, filed 12 Aug 2022.